vTv Therapeutics Inc. (VTVT) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 103 transactions totaling $91.0M, demonstrating a bullish sentiment with $90.8M in net insider flow. The most recent transaction on Sep 22, 2025 involved a transaction of 106,000 shares valued at $1.6M.
No significant insider buying has been recorded for VTVT in the recent period.
No significant insider selling has been recorded for VTVT in the recent period.
Based on recent SEC filings, insider sentiment for VTVT is bullish with an Insider Alignment Score of 100/100 and a net flow of $90.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at vTv Therapeutics Inc. (VTVT) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading VTVT stock, having executed 103 transactions in the past 90 days. The most active insider is Ronald O. Perelman (Executive), who has made 65 transactions totaling $89.9M.
Get notified when executives and directors at VTVT file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Sep 22, 2025 | Akkaraju Srinivas | Executive | Award | 106,000 | $15.27 | $1.6M | Large |
| Sep 3, 2025 | Baker Julian | Executive | Award | 4,308 | $N/A | $0 | |
| Sep 3, 2025 | Baker Julian | Executive | Award | 46,692 | $N/A | $0 | |
| Mar 5, 2024 | 667, L.p. | Executive | Disposition | 52,881 | $N/A | $0 | |
| Mar 5, 2024 | 667, L.p. | Executive | Disposition | 4,776 | $N/A | $0 | |
| Feb 27, 2024 | Akkaraju Srinivas | Executive | Award | 224,732 | $11.81 | $2.7M | Large |
| Nov 29, 2022 | A. Fry John | Executive | Purchase | 40,461 | $0.83 | $33.6K | |
| Nov 28, 2022 | A. Fry John | Executive | Purchase | 20,539 | $0.83 | $17.0K | |
| Dec 20, 2021 | O. Perelman Ronald | Executive | Sale | 87,000 | $1.15 | $100.0K | |
| Feb 26, 2021 | Kozlov Hersh | Executive | Purchase | 10,000 | $2.74 | $27.4K | |
| Feb 26, 2021 | S. Nelson Rich | Executive | Purchase | 10,000 | $2.86 | $28.6K | |
| Feb 26, 2021 | S. Nelson Rich | Executive | Purchase | 50,000 | $2.86 | $143.0K | |
| Dec 17, 2020 | O. Perelman Ronald | Executive | Purchase | 625,000 | $1.60 | $1.0M | Large |
| Dec 10, 2020 | O. Perelman Ronald | Executive | Purchase | 625,000 | $1.60 | $1.0M | Large |
| Nov 24, 2020 | O. Perelman Ronald | Executive | Purchase | 625,000 | $1.60 | $1.0M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 92 | $90.9M | 95.4% |
Award(A) | 4 | $4.3M | 4.5% |
Sale(S) | 1 | $100.0K | 0.1% |
Disposition(D) | 2 | $0 | 0.0% |
Exercise(M) | 3 | $0 | 0.0% |
Conversion(C) | 1 | $0 | 0.0% |
Insiders at vTv Therapeutics Inc. are accumulating shares at an accelerated pace. With 12 insiders making 103 transactions totaling $90.9M in purchases versus $100.0K in sales, the net buying activity of $90.8M signals strong executive confidence. Ronald O. Perelman (Executive) leads the buying activity with $89.9M in transactions across all time.